Peer-influenced content. Sources you trust. No registration required. This is HCN.
Fox Chase Cancer Center
Statistical models incorporating individual clinical and tumor characteristics showed superior accuracy when validated against standardized clinical trial data compared to retrospective prediction tools.
Oncology, Medical June 24th 2025
Healthgrades for Professionals
Urine color, transparency, and frequency patterns serve as accessible health indicators that patients can monitor independently while recognizing when professional medical evaluation becomes essential.
Emergency Medicine June 17th 2025
Health
Topical finasteride absorption through skin into bloodstream produces adverse events consistent with approved oral finasteride products, with 32 documented cases including erectile dysfunction, anxiety, and cognitive symptoms reported between 2019-2024.
Dermatology May 28th 2025
Oncology News Central (ONC)
Company leadership demands FDA explanation for approving identical treatment in patients with CIS while refusing filing for those without CIS, despite same trial data showing comparable clinical benefits and safety profiles.
Oncology, Medical May 27th 2025
UCLA Health
The procedure addresses limitations of current intestinal reconstruction methods, potentially eliminating associated bleeding risks, infections, and digestive complications while providing more physiologically normal urinary function.
Nephrology May 27th 2025
Endocrinology Advisor
Gepotidacin demonstrated superiority to nitrofurantoin in the EAGLE-3 trial with a therapeutic success rate of 58.9% versus 44%, while maintaining a manageable side effect profile primarily consisting of gastrointestinal disturbances.
Family Medicine/General Practice May 7th 2025